Gabriel Simon Breuer

Gabriel Simon Breuer

Auto-generated profile, based on publicly available information

Gabriel Simon Breuer

Shaare Zedek Medical Center

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Autoimmunity Reviews
Verified
Journal Article
Closed access
GBGabriel S. Breuer
Gabriel S. Breuer
ABAsher Baer
Asher Baer
DDDavid Dahan
David Dahan
GNGideon Nesher
Gideon Nesher

1 February 2006 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
GNGideon Nesher
Gideon Nesher
GBGabriel S. Breuer
Gabriel S. Breuer
KTKatherine Temprano
Katherine Temprano
TMTerry L. Moore
Terry L. Moore
DDDavid Dahan
David Dahan
MHMoshe Hersch
Moshe Hersch

17 February 2009 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
GBGabriel S. Breuer
Gabriel S. Breuer
GNGideon Nesher
Gideon Nesher
RNRonit Nesher
Ronit Nesher
Objective. To determine to what extent performing simultaneous bilateral temporal artery biopsies might increase the diagnostic sensitivity in giant cell arteritis (GCA).

22 July 2010 in Journal of Medical Toxicology
Verified
Journal Article
Closed access
PDF file
VFVictoria Furer
Victoria Furer
MHMoshe Hersch
Moshe Hersch
NSNoa Silvetzki
Noa Silvetzki
GBGabriel S. Breuer
Gabriel S. Breuer
SZShoshana Zevin
Shoshana Zevin

31 October 2016 in Rambam Maimonides Medical Journal
Verified
Journal Article
Open access
GNGideon Nesher
Gideon Nesher
GBGabriel S. Breuer
Gabriel S. Breuer
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are both more common among people of North European decent than among Mediterranean people. Women are 2-3 times more commonly affected. Giant cell arteritis and PMR are extremely rare before age 50 years. Polymyalgia rheumatica may be "isolated" or associated with GCA. There is increased expression of inflammatory cytokines in temporal arteries of PMR patients, without overt histological evidence of arteritis. One-third of "isolated" PMR patients have vascular uptake in positron emission tomography (PET) scans, suggesting clinically unrecognized, "hidden" GCA. Typical manifestations of GCA are headache, tenderness over temporal arteries, jaw claudication, PMR, acute vision loss, and low-grade fever. Bilateral aching of the shoulders with morning stiffness is typical for PMR. In both conditions sedimentation rate and C-reactive protein are elevated, and anemia and thrombocytosis may occur. Color duplex ultrasonography of the temporal arteries may aid in GCA diagnosis. Temporal artery biopsy showing vasculitis, often with giant cells, confirms GCA diagnosis. In cases with negative biopsy one must rely on the clinical presentation and laboratory abnormalities. The diagnosis of PMR is made primarily on clinical grounds. Other conditions that may mimic GCA or PMR must be excluded. Glucocorticoids are the treatment of choice for both conditions. Prompt treatment is crucial in GCA, to prevent irreversible complications of acute vision loss and stroke. Addition of low-dose aspirin may further prevent these complications. The average duration of treatment is 2-3 years, but some patients require a prolonged course of treatment, and some may develop disease-related or treatment-related complications. No steroid-sparing agent has been proven to be widely effective thus far, but some promising therapeutic agents are currently being studied.

1 April 1995 in Journal of Autoimmunity
Verified
Journal Article
Closed access
ABArie Ben-Yehuda
Arie Ben-Yehuda
LRLinda Rasooly
Linda Rasooly
RARuth Bar-Tan a
Ruth Bar-Tan a
GBGabriel Breuer
Gabriel Breuer
BTBoaz Tadmor
Boaz Tadmor
YNYaakov Naparstek
Yaakov Naparstek